Bullish Moving Averages
15
Bearish Moving Averages
1
Back Stocks profile
Stock analysis tool for investors
Open an Account with Bigul in 5 minutes
Performance
Today’s low
953.10Today’s High
981.6052W low
621.6052W High
1094.00Open Price
973.80Prev. Close
893.2000Volume
68568.00Value
65653860.00Fundamentals
Market Cap Cr
18820.90
Price to Earnings
30.60
Price to Book Value
3.90
Dividend Yield
0.80
PE to Growth
0.40
Op Revenue TTM Cr
6228.63
Net Profit TTM Cr
615.82
Cash From Operating Activity Cr
803.20
Return on Equity %
12.78
EMA & SMA
DELIVERY AND VOLUME
DAILY AVG. DELIVERY VOLUME %
02 Jul, 2024
37.9
Week
40.9
Month
49.4
LEGEND
Positive Indicator
Neutral Indicator
Negative Indicator
RESISTANCE AND SUPPORT
961.62
PIVOT
First Resistance
996.18
Second Resistance
1018.57
Third Resistance
1053.13
First Support
939.23
Second Support
904.67
Third Support
882.28
Relative Strength Index
63.51
Money Flow Index
56.52
MACD
-4.67
MACD Signal
-15.11
Average True Range
35.07
Average Directional Index
23.62
Rate of Change (21)
5.49
Rate of Change (125)
28.23
Commodity Channel Index
281.8
Williams %R
-7
BETA
1 Month
0.64
3 Month
0.65
1 Year
0.67
3 Year
0.22
PRICE CHANGE ANALYSIS
↑ 5.51%
1 Week
Low
High
870.2
984
↑ 3.73%
1 Month
Low
High
823.4
984
↓ -4.32%
3 Months
Low
High
823.4
1050.8
↑ 20.83%
6 Months
Low
High
787.55
1094
↑ 50.46%
1 Year
Low
High
621.65
1094
| Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 1481.77 | 1591.69 | 1487.80 | 1344.12 | 1309.08 | 1310.79 | 1354.89 | 1160.95 | 1315.91 | 1234.25 | 1191.48 | |
| Operating Expenses Qtr | 1186.36 | 1251.25 | 1271.38 | 1166.54 | 1137.94 | 1085.98 | 1109.13 | 1033.70 | 1013.01 | 950.08 | 952.82 | |
| Operating Profit Qtr | 288.19 | 337.14 | 207.46 | 165.73 | 169.18 | 224.23 | 245.29 | 126.63 | 291.30 | 282.75 | 236.95 | |
| EBIDT Qtr Cr | 295.41 | 340.44 | 216.41 | 177.57 | 171.14 | 224.81 | 245.76 | 127.25 | 302.90 | 284.16 | 238.66 | |
| Depreciation Qtr | 69.12 | 69.08 | 67.18 | 65.75 | 73.54 | 65.85 | 66.80 | 46.09 | 45.95 | 45.34 | 44.53 | |
| Net Profit Qtr | 201.87 | 233.24 | 133.84 | 97.53 | 130.54 | 119.13 | 146.44 | 72.46 | 251.37 | 193.58 | 156.35 | |
| Basic EPS Qtr | 10.27 | 11.87 | 6.81 | 4.96 | 6.64 | 6.06 | 7.45 | 3.69 | 12.79 | 9.85 | 7.95 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 5905.38 | 5152.54 | 5086.55 | 5061.17 | 4267.30 | |
| Operating Expenses Annual Cr | 4875.54 | 4484.65 | 4126.61 | 3479.21 | 2929.65 | |
| Operating Profit Annual | 998.52 | 664.35 | 908.80 | 1572.23 | 1202.90 | |
| Operating Profit Margin Annual % | 16.91 | 12.89 | 17.87 | 31.06 | 28.19 | |
| Total Expenses Annual Cr | 5201.15 | 4806.60 | 4428.55 | 3644.58 | 3090.51 | |
| EBIDT Annual Cr | 1029.84 | 667.89 | 959.94 | 1581.96 | 1337.65 | |
| EBIDT Annual margin % | 17.44 | 12.96 | 18.87 | 31.26 | 31.35 | |
| Depreciation | 271.14 | 272.95 | 284.92 | 152.60 | 135.67 | |
| PAT Before ExtraOrdinary Items Annual Cr | 666.48 | 346.73 | 543.55 | 1175.39 | 969.40 | |
| Net Profit Annual | 666.48 | 346.73 | 543.55 | 1175.39 | 969.40 | |
| Basic EPS Annual | 33.91 | 17.64 | 27.65 | 60.67 | 51.42 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 4908.91 | 4414.29 | 5290.34 | 5254.24 | 3346.02 | |
| Minority Interest Liability Annual Cr | - | - | - | - | - | |
| Total Non Current Liabilities Annual Cr | 162.42 | 164.83 | 204.25 | 398.47 | 1079.26 | |
| Total Current Liabilities Annual Cr | 1327.21 | 1551.30 | 1579.45 | 1123.47 | 1453.49 | |
| Total Capital Plus Liabilities Annual Cr | 6398.54 | 6130.42 | 7074.04 | 6776.18 | 5878.77 | |
| Fixed Assets Annual | 3060.02 | 2978.73 | 4075.33 | 3388.81 | 2846.44 | |
| Total Non Current Assets Annual | 3409.99 | 3350.20 | 4329.58 | 4402.23 | 3727.40 | |
| Total Current Assets Annual | 2988.55 | 2780.22 | 2744.46 | 2373.95 | 2151.37 | |
| Total Assets Annual | 6398.54 | 6130.42 | 7074.04 | 6776.18 | 5878.77 | |
| Contingent Liabilities plus Commitments Annual Cr | 193.55 | 326.18 | 228.15 | 327.06 | 455.59 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | 772.77 | 730.25 | 545.26 | 1485.30 | 539.75 | |
| Cash from Investing Activity Annual | -329.02 | -460.98 | -368.72 | -925.55 | -822.31 | |
| Cash from Financing Annual Activity | -445.29 | -261.16 | -216.64 | -533.60 | 166.13 | |
| Net Cash Flow Annual | -1.54 | 8.11 | -40.10 | 26.15 | -116.43 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 249.75 | 224.59 | 269.16 | 267.32 | 177.51 | |
| ROE Annual % | 13.57 | 7.85 | 10.27 | 22.37 | 28.97 | |
| ROCE Annual % | 14.96 | 8.62 | 12.28 | 25.28 | 27.16 | |
| Total Debt to Total Equity Annual | 0.09 | 0.14 | 0.12 | 0.04 | 0.50 | |
| EBDIT Annual Margin % | 17.53 | 12.97 | 19.06 | 31.31 | 32.36 |
| Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 1520.58 | 1633.46 | 1605.09 | 1497.81 | 1407.34 | 1509.46 | 1475.34 | 1263.22 | 1426.01 | 1273.04 | 1294.52 | |
| Operating Expenses Qtr | 1256.92 | 1364.21 | 1386.69 | 1287.46 | 1194.23 | 1260.27 | 1242.27 | 1247.49 | 1255.63 | 1016.05 | 1035.09 | |
| Operating Profit Qtr | 260.06 | 266.36 | 208.25 | 198.69 | 212.22 | 248.75 | 232.74 | 14.65 | 160.11 | 255.65 | 257.23 | |
| EBIDT Qtr Cr | 263.66 | 269.25 | 218.40 | 210.35 | 213.11 | 249.19 | 233.07 | 15.73 | 170.38 | 257.00 | 259.43 | |
| Depreciation Qtr | 69.48 | 69.45 | 67.56 | 66.18 | 74.12 | 66.51 | 67.70 | 67.10 | 123.08 | 55.94 | 54.60 | |
| Net Profit Qtr | 178.21 | 180.45 | 136.56 | 120.60 | 152.60 | 121.92 | 133.35 | -65.88 | 35.46 | 176.42 | 169.29 | |
| Basic EPS Qtr | 9.07 | 9.18 | 6.95 | 6.14 | 7.76 | 6.20 | 6.78 | -3.35 | 1.80 | 8.98 | 8.61 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 6256.93 | 5655.36 | 5356.25 | 5403.15 | 4610.69 | |
| Operating Expenses Annual Cr | 5295.27 | 4944.24 | 4431.63 | 3835.58 | 3382.73 | |
| Operating Profit Annual | 933.35 | 708.38 | 874.16 | 1557.55 | 1223.02 | |
| Operating Profit Margin Annual % | 14.92 | 12.53 | 16.32 | 28.83 | 26.53 | |
| Total Expenses Annual Cr | 5624.13 | 5269.84 | 4736.14 | 4035.07 | 3567.21 | |
| EBIDT Annual Cr | 961.66 | 711.12 | 924.62 | 1567.57 | 1227.96 | |
| EBIDT Annual margin % | 15.37 | 12.57 | 17.26 | 29.01 | 26.63 | |
| Depreciation | 272.67 | 275.43 | 286.78 | 183.47 | 157.32 | |
| PAT Before ExtraOrdinary Items Annual Cr | 616.80 | 372.91 | 515.65 | 1114.76 | 800.65 | |
| Net Profit Annual | 615.82 | 341.99 | 520.94 | 1178.11 | 828.82 | |
| Basic EPS Annual | 31.33 | 17.40 | 26.50 | 60.81 | 43.97 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 4818.20 | 4370.47 | 5237.54 | 5127.61 | 3219.41 | |
| Minority Interest Liability Annual Cr | 0.00 | 0.00 | 0.00 | -60.64 | -28.96 | |
| Total Non Current Liabilities Annual Cr | 172.39 | 175.43 | 167.96 | 361.16 | 1046.99 | |
| Total Current Liabilities Annual Cr | 1454.99 | 1636.93 | 1716.53 | 1280.85 | 1751.60 | |
| Total Capital Plus Liabilities Annual Cr | 6445.58 | 6182.83 | 7122.03 | 6708.98 | 5989.04 | |
| Fixed Assets Annual | 3071.07 | 2999.73 | 4102.08 | 3970.96 | 3398.02 | |
| Total Non Current Assets Annual | 3367.02 | 3272.81 | 4261.24 | 4131.08 | 3526.30 | |
| Total Current Assets Annual | 3078.56 | 2910.02 | 2860.79 | 2577.90 | 2462.74 | |
| Total Assets Annual | 6445.58 | 6182.83 | 7122.03 | 6708.98 | 5989.04 | |
| Contingent Liabilities plus Commitments Annual Cr | 183.13 | 317.96 | 228.15 | 349.23 | 386.98 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | 803.20 | 723.95 | 552.36 | 1463.38 | 449.13 | |
| Cash from Investing Activity Annual | -320.61 | -447.59 | -371.97 | -838.81 | -731.63 | |
| Cash from Financing Annual Activity | -437.86 | -261.96 | -217.36 | -597.42 | 154.86 | |
| Net Cash Flow Annual | 44.73 | 14.40 | -36.97 | 27.15 | -127.64 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 245.14 | 222.36 | 266.47 | 257.80 | 169.25 | |
| ROE Annual % | 12.78 | 7.82 | 9.94 | 22.97 | 25.74 | |
| ROCE Annual % | 13.80 | 9.58 | 11.79 | 25.49 | 25.26 | |
| Total Debt to Total Equity Annual | 0.09 | 0.15 | 0.12 | 0.04 | 0.54 | |
| EBDIT Annual Margin % | 15.43 | 12.58 | 17.42 | 29.06 | 26.66 |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| Kotak Small Cap Fund | 1.76 | 74393548 | - | - |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| Chirayu Ramanbhai Amin | 2.13 | 74393510 | 0 | 0 |
| Malika Chirayu Amin | 1.53 | 74393511 | 0 | 0 |
| Pranav Chirayu Amin | 0.51 | 74393512 | 0 | 0 |
| Shaunak Chirayu Amin | 0.51 | 74393513 | 0 | 0 |
| Nirayu Limited | 35.63 | 74393521 | 0 | 0 |
| Alembic Limited | 28.54 | 74393522 | 0 | 0 |
| Udit Chirayu Amin | 0.51 | 74393543 | 0 | 0 |
| Name | Holding Percent | Holding Id |
|---|---|---|
| DSP Midcap Fund | 3.92 | 74393547 |
| Kotak Small Cap Fund | 1.76 | 74393548 |
| Life Insurance Corporation Of India | 4.33 | 74393550 |
| Name | Holding Percent | Holding Id |
|---|
| Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| Jul 15, 2024 | 11 | FINAL | Jul 15, 2024 | Equity Share |
| Jul 28, 2023 | 8 | FINAL | Jul 28, 2023 | Equity Share |
| Aug 17, 2022 | 10 | INTERIM | Aug 18, 2022 | Equity Share |
| Jul 19, 2021 | 14 | FINAL | - | Equity Share |
| Mar 16, 2020 | 7 | INTERIM | Mar 17, 2020 | Equity Share |
| Mar 16, 2020 | 3 | SPECIAL | Mar 17, 2020 | Equity Share |
| Jul 18, 2019 | 5.5 | FINAL | - | Equity Share |
| Jul 18, 2018 | 4 | FINAL | - | Equity Share |
| Jul 11, 2017 | 4 | FINAL | - | Equity Share |
| Jul 20, 2016 | 4 | FINAL | - | Equity Share |
| Jul 22, 2015 | 3.5 | FINAL | - | Equity Share |
| Jul 17, 2014 | 3 | FINAL | - | Equity Share |
| Jul 29, 2013 | 2.5 | FINAL | - | Equity Share |
| Jul 31, 2012 | 1.4 | FINAL | - | Equity Share |
| Ex-Date | Split Ratio | Record Date |
|---|
| Ex-Date | Purpose | Notes |
|---|---|---|
| May 09, 2024 | Audited Results & Final Dividend | - |
| Feb 05, 2024 | Quarterly Results | - |
| Nov 07, 2023 | Quarterly Results | - |
| Aug 04, 2023 | Quarterly Results | - |
| May 05, 2023 | Audited Results & Final Dividend | - |
| Feb 01, 2023 | Quarterly Results | - |
| Nov 11, 2022 | Quarterly Results | - |
| Aug 04, 2022 | Quarterly Results & Others | To change dividend type from Final Dividend to Interim Dividend |
| May 02, 2022 | Audited Results & Dividend | - |
| Feb 10, 2022 | Quarterly Results | - |
| Nov 10, 2021 | Quarterly Results | - |
| Jul 26, 2021 | Quarterly Results | - |
| May 04, 2021 | Audited Results & Dividend | - |
| Jan 19, 2021 | Quarterly Results | - |
| Oct 22, 2020 | Quarterly Results | - |
| Aug 06, 2020 | To consider raising of funds | - |
| Jul 27, 2020 | Others | Inter alia to consider fund raising by way of a qualified institutions placement. |
| Jul 22, 2020 | Quarterly Results | - |
| May 22, 2020 | Audited Results | - |
| Apr 23, 2020 | Quarterly Results | - |
| Mar 06, 2020 | Interim Dividend | - |
| Jan 22, 2020 | Quarterly Results | - |
| Oct 24, 2019 | Quarterly Results | - |
| Jul 29, 2019 | Quarterly Results | - |
| Jun 12, 2019 | Others | inter alia, to consider and approve the proposal for issue of NonConvertible Debentures on Private Placement Basis. |
| May 08, 2019 | Audited Results & Dividend | - |
| Jan 22, 2019 | Quarterly Results | - |
| Dec 14, 2018 | Others | To consider and approve the issue and allotment of Unsecured Redeemable Non-Convertible Debentures (NCDs) of upto Rs. 350 Crores on Private Placement Basis. |
| Dec 06, 2018 | Others | To consider and approve a fresh proposal for issue of Non-Convertible Debentures on Private Placement Basis, superceding the earlier resolution. |
| Oct 22, 2018 | Quarterly Results | - |
| Sep 10, 2018 | Others | To consider the proposal for issue of Non-Convertible Debentures on Private Placement Basis. |
| Jul 27, 2018 | Quarterly Results | - |
| May 16, 2018 | Audited Results & Dividend | - |
| Jan 31, 2018 | Quarterly Results | - |
| Nov 07, 2017 | Quarterly Results | - |
| Jul 20, 2017 | Quarterly Results | - |
| May 03, 2017 | Audited Results & Dividend | - |
| Jan 25, 2017 | Quarterly Results | - |
| Oct 25, 2016 | Quarterly Results | - |
| Jul 29, 2016 | Quarterly Results | - |
| Apr 27, 2016 | Audited Results & Dividend | - |
| Jan 21, 2016 | Quarterly Results | - |
| Oct 27, 2015 | Quarterly Results | - |
| Jul 31, 2015 | Quarterly Results | - |
| Apr 27, 2015 | Audited Results & Dividend | Appointed Mr. Pranav Amin as Joint Managing Director w.e.f. April 27, 2015. |
| Feb 04, 2015 | Quarterly Results | - |
| Oct 20, 2014 | Quarterly Results | - |
| Jul 28, 2014 | Quarterly Results | - |
| Apr 28, 2014 | Audited Results & Dividend | - |
| Jan 22, 2014 | Quarterly Results | - |
| Oct 25, 2013 | Quarterly Results | (Revised) |
| Aug 07, 2013 | Quarterly Results | - |
| May 02, 2013 | Audited Results & Dividend | - |
| Jan 21, 2013 | Quarterly Results | - |
| Oct 19, 2012 | Quarterly Results | - |
| Aug 09, 2012 | Quarterly Results | - |
| Apr 25, 2012 | Audited Results & Dividend | - |
| Feb 08, 2012 | Quarterly Results | - |
| Oct 19, 2011 | Quarterly Results | - |
| Ex-Date | Bonus Ratio | Record Date |
|---|
01 Jul 2024
ALEMBIC PHARMACEUTICALS LTD. - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Alembic Pharmaceuticals Limited has received USFDA Tentative Approval for Bosutinib Tablets 100mg and 500 mg.
28 Jun 2024
ALEMBIC PHARMACEUTICALS LTD. - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Alembic Pharmaceuticals receives USFDA Final Approval for Doxycycline Capsules 40mg.
26 Jun 2024
ALEMBIC PHARMACEUTICALS LTD. - 533573 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Please find attached herewith the Intimation received from our RTA.
26 Jun 2024
ALEMBIC PHARMACEUTICALS LTD. - 533573 - Closure of Trading Window
Please find attached the Intimation of Closure of Trading Window
24 Jun 2024
ALEMBIC PHARMACEUTICALS LTD. - 533573 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find attached herewith the Newspaper Publication.
21 Jun 2024
ALEMBIC PHARMACEUTICALS LTD. - 533573 - Intimation Of Record Date For Dividend Payment
Intimation of Record Date for Payment of Dividend.
21 Jun 2024
ALEMBIC PHARMACEUTICALS LTD. - 533573 - Business Responsibility and Sustainability Reporting (BRSR)
Please find attached herewith the BRSR of the Company for the Financial Year 2023-24.
21 Jun 2024
ALEMBIC PHARMACEUTICALS LTD. - 533573 - Reg. 34 (1) Annual Report.
Please find attached herewith the 14th Annual Report of the Company.
21 Jun 2024
ALEMBIC PHARMACEUTICALS LTD. - 533573 - Notice Of 14Th AGM To Be Held On Monday, 22Nd July, 2024.
Please find attached herewith the Notice of the 14th AGM of the Company to be held on Monday, 22nd July, 2024.
18 Jun 2024
ALEMBIC PHARMACEUTICALS LTD. - 533573 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Please find attached herewith the intimation received from our RTA.
